Treatment failure due to methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin

被引：60
|
作者：
Ward, PB
Johnson, PDR
Grabsch, EA
Mayall, BC
Grayson, ML
机构：
[1] Austin & Repatriat Med Ctr, Dept Microbiol, Heidelberg, Vic 3084, Australia
[2] Austin & Repatriat Med Ctr, Dept Infect Dis, Heidelberg, Vic 3084, Australia
来源：
MEDICAL JOURNAL OF AUSTRALIA | 2001年 / 175卷 / 09期
关键词：
D O I：
10.5694/j.1326-5377.2001.tb143681.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
We report the first instance in Australia of treatment failure due to a strain of methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin - heteroresistant vancomycin-intermediate S. aureus (hVISA). The infection occurred in a 41-year-old man with multiple risk factors. No transmission of the organism to other patients or the environment was detected. This case may herald the beginning of a new phase of staphylococcal resistance in Australia.
引用
收藏
页码：480 / +
页数：5
相关论文
共 50 条
  • [1] Treatment failure due to methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin
    Grabs, AJ
    Lor, RSA
    MEDICAL JOURNAL OF AUSTRALIA, 2002, 176 (11) : 563 - 563
  • [2] Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA)
    Appelbaum, Peter C.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 30 (05) : 398 - 408
  • [3] Methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in Taiwan
    Lin, Chien-Yu
    Wang, Jui-Hsing
    Lin, Kai-Hsiang
    Ho, Yu-Ling
    Ho, Cheng-Mao
    TZU CHI MEDICAL JOURNAL, 2018, 30 (03): : 135 - 140
  • [4] Methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Canada
    Webster, Duncan
    Rennie, Robert P.
    Brosnikoff, Cheryl L.
    Chui, Linda
    Brown, Connie
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2007, 57 (02) : 177 - 181
  • [5] Reduced susceptibility to vancomycin of nosocomial isolates of methicillin-resistant Staphylococcus aureus
    Kantzanou, M
    Tassios, PT
    Tseleni-Kotsovili, A
    Legakis, NJ
    Vatopoulos, AC
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (05) : 729 - 731
  • [6] Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
    Hiramatsu, K
    Hanaki, H
    Ino, T
    Yabuta, K
    Oguri, T
    Tenover, FC
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (01) : 135 - 136
  • [7] Alternative agents for the treatment of invasive infections due to methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to vancomycin
    Tattevin, Pierre
    Arvieux, Cedric
    Michelet, Christian
    ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (11) : 1206 - 1206
  • [8] Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Infections in Children: a Reappraisal of Vancomycin
    Sharma, Roopali
    Hammerschlag, Margaret R.
    CURRENT INFECTIOUS DISEASE REPORTS, 2019, 21 (10)
  • [9] Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Infections in Children: a Reappraisal of Vancomycin
    Roopali Sharma
    Margaret R. Hammerschlag
    Current Infectious Disease Reports, 2019, 21
  • [10] First report of methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Thailand
    Trakulsomboon, S
    Danchaivijitr, S
    Rongrungruang, Y
    Dhiraputra, C
    Susaemgrat, W
    Ito, T
    Hiramatsu, K
    JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (02) : 591 - 595
12345